IRIS
DANIELLI, RICCARDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.803
EU - Europa 1.371
AS - Asia 781
SA - Sud America 102
AF - Africa 31
OC - Oceania 1
Totale 4.089
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.774
RU - Federazione Russa 379
SG - Singapore 327
CN - Cina 221
GB - Regno Unito 218
IT - Italia 218
IE - Irlanda 213
BR - Brasile 85
VN - Vietnam 84
DE - Germania 78
SE - Svezia 71
FR - Francia 65
HK - Hong Kong 57
UA - Ucraina 46
FI - Finlandia 24
ZA - Sudafrica 24
ES - Italia 22
BD - Bangladesh 15
CA - Canada 15
KR - Corea 15
MX - Messico 11
IN - India 10
PL - Polonia 7
JP - Giappone 6
AZ - Azerbaigian 5
CO - Colombia 5
NL - Olanda 5
PK - Pakistan 5
AR - Argentina 4
AT - Austria 4
IQ - Iraq 4
TR - Turchia 4
BE - Belgio 3
EC - Ecuador 3
LT - Lituania 3
NP - Nepal 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
BG - Bulgaria 2
BH - Bahrain 2
CH - Svizzera 2
HR - Croazia 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
MY - Malesia 2
NG - Nigeria 2
OM - Oman 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
AU - Australia 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CL - Cile 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
GR - Grecia 1
IL - Israele 1
IR - Iran 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
MK - Macedonia 1
MU - Mauritius 1
NO - Norvegia 1
PH - Filippine 1
PY - Paraguay 1
SY - Repubblica araba siriana 1
TL - Timor Orientale 1
UY - Uruguay 1
VE - Venezuela 1
Totale 4.089
Salva come PNG Salva come JPEG
Città #
Fairfield 232
Dublin 213
Singapore 199
Southend 182
Ashburn 154
Dallas 143
Woodbridge 100
Moscow 95
Houston 94
Cambridge 91
San Jose 90
Seattle 88
Santa Clara 81
Beijing 79
Wilmington 78
Hong Kong 57
Milan 55
Siena 50
Jacksonville 44
Chandler 40
Ann Arbor 39
Princeton 33
The Dalles 31
Shanghai 28
Los Angeles 27
Ho Chi Minh City 25
New York 25
Lauterbourg 22
Johannesburg 21
Council Bluffs 19
Helsinki 19
Rome 19
San Mateo 18
Málaga 17
Hanoi 15
Dearborn 14
San Diego 13
Hefei 12
Dong Ket 11
Munich 11
Nanjing 11
San Francisco 10
Florence 9
Denver 8
Buffalo 7
Düsseldorf 7
Montreal 7
Orem 7
Palermo 7
Phoenix 7
Seoul 7
Stockholm 7
Brooklyn 6
London 6
Poplar 6
São Paulo 6
Yongsan-gu 6
Baku 5
Boston 5
Chicago 5
Frankfurt am Main 5
Toronto 5
Venezia 5
Warsaw 5
Da Nang 4
Figino 4
Labico 4
Mexico City 4
Nanchang 4
Norwalk 4
Porto Alegre 4
Redondo Beach 4
Tokyo 4
Amsterdam 3
Asciano 3
Boardman 3
Brussels 3
Dhaka 3
Guangzhou 3
Kunming 3
Naples 3
Ninh Bình 3
Pistoia 3
Portsmouth 3
Redwood City 3
Rio de Janeiro 3
Riyadh 3
Tashkent 3
Vienna 3
Abuja 2
Ankara 2
Araras 2
Atlanta 2
Bari 2
Barnet 2
Benito Juarez 2
Bogotá 2
Bologna 2
Bratislava 2
Brescia 2
Totale 2.849
Salva come PNG Salva come JPEG
Nome #
Ipilimumab experience in heavily pretreated patients with melanoma in an expanded access program at the University Hospital of Siena (Italy) 354
Long-term survival and immunological parameters in metastatic melanoma patients who responded to ipilimumab 10 mg/kg within an expanded access programme 331
Long-term follow up of metastatic melanoma patients treated with Thymosin alpha-1: investigating immune checkpoints synergy 273
Circulating levels of PD-L1 in mesothelioma patients from the NIBIT-MESO-1 study: Correlation with survival 257
Adjuvant vemurafenib in resected, BRAF V600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial 255
Ipilimumab in pretreated metastatic uveal melanoma patients: safety and clinical efficacy 252
Guadecitabine plus ipilimumab in unresectable melanoma: the NIBIT-M4 clinical trial 231
Epigenetically regulated clonal heritability of CTA expression profiles in human melanoma 209
“Cancer Bio-Immunotherapy in Siena”: Eleventh Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 17–19, 2013 202
Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies 196
Ipilimumab in the common daily practice: feasibility, safety, efficacy and long-term follow-up in heavily pretreated metastatic melanoma patients 188
Clinical studies with anti-CTLA-4 antibodies in non-melanoma indications 187
Immunotherapy targeting immune check-point(s) in brain metastases 181
Clinical Efficacy of the Anti-Cytotoxic T Lymphocyte Antigen-4 (CTLA-4) Monoclonal Antibody Ipilimumab in Pretreated Metastatic Uveal Melanoma Patients 178
Eruptive porokeratosis under nivolumab adjuvant treatment for melanoma 178
Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian network for tumor biotherapy (NIBIT)-M1 phase II study 165
ICOS expression as immunologic marker in immune activating monoclonal antibodies 151
Efficacy of ipilimumab plus nivolumab or ipilimumab plus fotemustine vs fotemustine in patients with melanoma metastatic to the brain: Primary analysis of the phase III NIBIT-M2 trial 141
Efficacy and safety of an intensified schedule of tremelimumab for chemotherapy-resistant malignant mesothelioma: An open-label, single-arm, phase 2 study 119
Tremelimumab combined with durvalumab in patients with mesothelioma (NIBIT-MESO-1): an open-label, non-randomised, phase 2 study 116
Totale 4.164
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.609
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.609
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022259 19 38 23 5 11 12 14 14 13 32 28 50
2022/2023265 19 22 50 20 9 45 10 28 16 18 15 13
2023/2024318 11 7 52 12 7 72 121 4 0 0 14 18
2024/2025520 15 24 57 21 73 37 4 20 92 17 54 106
2025/20261.478 93 125 106 206 430 67 152 38 23 62 42 134
2026/202728 28 0 0 0 0 0 0 0 0 0 0 0
Totale 4.164